KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Operating Leases (2019 - 2026)

Supernus Pharmaceuticals has reported Operating Leases over the past 7 years, most recently at $41.0 million for Q4 2025.

  • Quarterly Operating Leases rose 49.65% to $41.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41.0 million through Dec 2025, up 49.65% year-over-year, with the annual reading at $41.0 million for FY2025, 49.65% up from the prior year.
  • Operating Leases was $41.0 million for Q4 2025 at Supernus Pharmaceuticals, up from $31.4 million in the prior quarter.
  • Over five years, Operating Leases peaked at $46.0 million in Q1 2022 and troughed at $24.4 million in Q2 2025.
  • The 5-year median for Operating Leases is $37.7 million (2021), against an average of $36.8 million.
  • Year-over-year, Operating Leases soared 61.33% in 2022 and then plummeted 39.01% in 2025.
  • A 5-year view of Operating Leases shows it stood at $41.3 million in 2021, then decreased by 12.83% to $36.0 million in 2022, then grew by 15.36% to $41.5 million in 2023, then crashed by 34.06% to $27.4 million in 2024, then soared by 49.65% to $41.0 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Operating Leases are $41.0 million (Q4 2025), $31.4 million (Q3 2025), and $24.4 million (Q2 2025).